ClinicalTrials.Veeva

Menu

Pulmonary Hypertension in Lymphangioleiomyomatosis (LAM-PH)

G

Groupe d'Etudes et de Recherche sur les Maladies Orphelines Pulmonaires

Status

Completed

Conditions

Lymphangioleiomyomatosis
Pulmonary Hypertension

Study type

Observational

Funder types

Other

Identifiers

NCT00960895
GERMOP-001

Details and patient eligibility

About

This is a descriptive study of patients with Lymphangioleiomyomatosis and precapillary pulmonary hypertension.

Full description

Descriptive study of patients with Lymphangioleiomyomatosis and precapillary pulmonary hypertension This will include modality of diagnosis of lLymphangioleiomyomatosis, results of right-sided heart catheterization, and pulmonary function tests

Enrollment

20 patients

Sex

Female

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Lymphangioleiomyomatosis (definite or probable), either sporadic or associated with tuberous sclerosis
  • Precapillary pulmonary hypertension, as defined by right-sided heart catheterization (mean pulmonary artery pressure higher than 25 mmHg, wedge capillary pulmonary pressure less than 15 mmHg, pulmonary vascular resistance higher than 3 Wood units)

Exclusion criteria

  • Post capillary pulmonary hypertension
  • Other identifiable causes of pulmonary hypertension (ex: thromboembolic disease)
  • Not willing to participate

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems